why choose us

First received: July 26, 2023

Clinical Trial: Clinical Study of 18F-FAPI-RGD in Breast Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Breast Tumors

Study Type: OBSERVATIONAL


Official Title: Clinical Study of 18F Labeled Probe Targeting Fibroblast Activation Protein Inhibitor and Integrin av?3 (FAPI-RGD) in Breast Tumors

Brief Summary: The goal of this observational study is to learn about the value of 18F-FAPI-RGD PET/CT imaging in Breast Tumors.Participants will undergo clinical evaluation and 18F-FAPI-RGD PET/CT examination.

Read more